TGF-beta 3 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-82416
Key Product Details
Species Reactivity
Mouse, Rat
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.5 mg/ml
Product Specifications
Immunogen
Synthetic peptide towards TGF beta 3. Peptide sequence ILRPDEHIAKQRYIGGKNLPTRGTAEWLSFDVTDTVREWLLRRESNLGLE. The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
The addition of 50% glycerol is optional for those storing this antibody at -20C and not aliquoting smaller units. However, please note that glycerol may interrupt some downstream antibody applications and should be added with caution.
Scientific Data Images for TGF-beta 3 Antibody
Western Blot: TGF-beta 3 Antibody [NBP1-82416]
Western Blot: TGF-beta 3 Antibody [NBP1-82416] - Host: Mouse. Target Name: TGFB3. Sample Tissue: Mouse Small Intestine. Antibody Dilution: 1ug/mlWestern Blot: TGF-beta 3 Antibody [NBP1-82416]
Western Blot: TGF-beta 3 Antibody [NBP1-82416] - Rat Liver Lysate 1ug/ml Gel Concentration 12%Applications for TGF-beta 3 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: TGF-beta 3
Long Name
Transforming Growth Factor beta 3
Alternate Names
ARVD1, LDS5, RNHF, TGFB3, TGFbeta 3
Gene Symbol
TGFB3
UniProt
Additional TGF-beta 3 Products
Product Documents for TGF-beta 3 Antibody
Product Specific Notices for TGF-beta 3 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...